Multiple Dose Study of MPC-6827 in Subjects With Refractory Brain Metastases

Clinical trial NCT00393965 · COMPLETED

Trial details

NCT number: NCT00393965
Sponsor: Myrexis Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Brain Neoplasms

Start date: 2005-12-01
Primary completion: 2007-08-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.